Haematoma complicating subcutaneous fat necrosis of the newborn: a rare complication following therapeutic hypothermia

  1. Elhaytham Omar Sanad Elsayed 1,
  2. Kamran Yusuf 1,
  3. Frankie O G Fraulin 2 and
  4. Prashanth Murthy 1
  1. 1 Pediatrics—Neonatology, University of Calgary, Calgary, Alberta, Canada
  2. 2 Section of Pediatric Surgery, Department of Surgery, Alberta Children’s Hospital, University of Calgary, Calgary, Alberta, Canada
  1. Correspondence to Dr Elhaytham Omar Sanad Elsayed; elhaytham1396@gmail.com

Publication history

Accepted:08 May 2020
First published:11 Jun 2020
Online issue publication:11 Jun 2020

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

A term, large for gestational age male newborn, was admitted to the neonatal intensive care unit with meconium aspiration syndrome and severe hypoxic-ischaemic encephalopathy. The baby was treated with therapeutic hypothermia using a total body cooling blanket. After 48 hours, the baby developed tender, indurated subcutaneous nodules consistent with subcutaneous fat necrosis (SCFN). The lesions started initially over the back but gradually spread to cover both shoulders, upper arms, chest area and both thighs. On day 19 of life, multiple small nodules on the back softened and coalesced to form one sizeable fluctuant swelling over the thoracolumbar area. Over a few hours, the swelling rapidly progressed to a large, tense mass with sloughing of the gangrenous overlying skin. This unusual complication of SCFN required surgical intervention for evacuation and debridement of the haematoma followed by graft repair of the skin defect.

Background

Neonatal hypoxic-ischaemic encephalopathy (HIE) is a major global health problem with more than one million new cases annually. Fifteen to twenty per cent of the affected neonates die in the neonatal period, and 40% suffer neurodevelopmental complications.1 Therapeutic hypothermia (TH) is a standard of care for term and near-term infants ≥35 weeks gestational age with moderate-to-severe HIE. Evidence from multiple randomised trials has established that TH improves survival without disability to infancy and mid-childhood.2 TH is generally safe. However, transient adverse effects commonly occur with TH in the background of asphyxia, including bradycardia, hypotension and prolonged coagulation profiles.3 Subcutaneous fat necrosis (SCFN) is a known complication of TH occurring in about 3% of patients undergoing TH for HIE.4 SCFN is a self-limited condition with occasional association with hypercalcaemia, which may be life threatening, requiring careful monitoring and treatment.5 We report an unusual case of SCFN that presented as a large, rapidly progressive subcutaneous haematoma requiring surgical intervention in a term baby following TH.

Case presentation

A male newborn weighing 3.99 kg (>90th% of birth weight and gestation) was delivered by caesarian section for decreased fetal movements after induced labour. The mother was G6P2, with a history of three previous spontaneous abortions. This pregnancy was complicated with gestational diabetes and hypothyroidism.

The baby was born through meconium-stained amniotic fluid. He was non-vigorous at birth with apnoea and bradycardia, requiring endotracheal intubation and chest compression for 3 min. Apgar scores were 1, 2, 4 and 4 at 1, 5, 10 and 15 min, respectively. Cord arterial pH was 6.69 and base deficit of −21.7. The baby had clinical signs of severe encephalopathy, and he was treated with TH using a total body cooling blanket. The target temperature of 33–34°C was reached at about 4 hours of age and continued for 72 hours. Seizures were noted at 2 hours of age, and his amplitude integrated electroencephalography tracing (aEEG) showed a burst suppression pattern. Brain MRI and magnetic resonance spectroscopy on day 5 of life showed evidence of injury in deep grey matter and watershed area with bilateral intraventricular haemorrhage associated with post haemorrhagic hydrocephalus.

The baby’s condition was complicated with meconium aspiration syndrome, which was treated with surfactant administration and high-frequency mechanical ventilation. The seizures were treated with phenobarbitone, levetiracetam and fosphenytoin. He had hypotension that required treatment with multiple fluid boluses, multiple inotropes and steroids. He developed pulmonary hypertension (PPHN) that was treated with inhaled nitric oxide (iNO), milrinone and prostaglandin E1 infusion. He had a low platelet count with abnormal coagulation profile that required multiple transfusions of platelets and fresh frozen plasma.

After 48 hours on total body cooling, the baby developed tender, indurated subcutaneous nodules consistent with SCFN. It initially started over the back but gradually spread to cover both shoulders, upper arms, chest area and both thighs (figure 1).

Figure 1

Multiple subcutaneous fat nodules of the back on day 10 of life.

Over the following days, the baby was gradually weaned from inotropic support but stayed on mechanical ventilation, iNO and milrinone for PPHN. He continued to receive daily platelet transfusion for thrombocytopenia. Serum calcium level was normal, and he was supplemented with oral vitamin D by day 14 of life as he reached full feeding of expressed breast milk.

On day 19 of life, multiple small nodules on the back softened and merged to form one large fluctuant swelling over the thoracolumbar area. The swelling was initially small, soft and tender but rapidly progressed over few hours to a large, tense mass measuring 10×7 × 7 cm with sloughing of a gangrenous overlying skin (figure 2). The baby’s clinical condition did not change on mechanical ventilation. He was haemodynamically and neurologically stable and received morphine for pain. The baby’s laboratory tests showed thrombocytopenia and abnormal coagulation profile, which improved after transfusion of platelet, fresh frozen plasma and cryoprecipitate.

Figure 2

Large subcutaneous haematoma of the back on day 19 of life.

Investigations

The ultrasonographic examination of the baby’s back revealed a well-defined oval heterogeneous mass with both solid and cystic components within the subcutaneous tissues. Its measurements were approximately 10.8×6.9×4.4 cm in size. With no internal vascularity on colour Doppler assessment, the lesion was considered to be a haematoma.

A sample from the skin and adipose tissue of the haematoma was sent for pathological analysis. Microscopic examination demonstrated extensive SCFN exhibiting classical features of SCFN of the newborn. The overlying skin appeared extensively necrotic. The pathological examination of the specimen did not identify an apparent cause for the described haematoma. The scattered vessels (arteries and veins) identified in the subcutis appeared normal.

Treatment

On day 23 of life, the baby underwent surgical evacuation and debridement of the haematoma under general anaesthesia. The overlying necrotic skin was excised at the same time, leaving an open wound measuring 13×7 cm on the baby’s back (figure 3).

Figure 3

The wound of the baby’s back after debridement of the haematoma on day 23 of life.

The large back wound that resulted was dressed with negative-pressure wound therapy (VAC, KCI Medical Canada, Mississauga, Ontario, Canada), which was increased gradually from 50 mm Hg to 150 mm Hg over several weeks to facilitate healing and decrease wound size.

Outcome and follow-up

On day 67 of life, a split-thickness skin graft harvested from the right thigh was used to cover the bare area on the baby’s back. The recovery went well with a 95% gain (figure 4). The baby was eventually transferred to a level 2 hospital on nasal cannula and full gavage tube feeding at 79 days of age.

Figure 4

The baby’s back 2 weeks after full-thickness skin graft surgery.

Discussion

SCFN is a rare, non-infective, self-limited panniculitis that typically affects term neonates during the first few days of life in the form of subcutaneous, tender erythematous nodules. It usually affects the areas with bony protrusions, mainly the back, shoulders, buttocks, arms, thighs and cheeks.4 6 7

Maternal risk factors linked to SCFN include maternal diabetes, preeclampsia, instrumental delivery and smoking. Neonatal risk factors are postdates, macrosomia, meconium aspiration, thrombocytopenia and hypothermia. The most common risk factors associated with SCFN are neonatal HIE and TH.5 6 8 SCFN was described in babies with birth asphyxia before the TH era, and it was described in babies exposed to hypothermia without evidence of birth asphyxia.9 In our case, the baby had the following risk factors; HIE, TH, meconium aspiration, thrombocytopenia and maternal diabetes.

The exact pathogenesis of the SCFN is unknown. It might be explained by the susceptibility of neonatal fat to hardening when exposed to cold temperature due to its higher content of saturated fatty acids and palmitic acids in comparison to adult fat.10

The infant in this report developed SCFN 48 hours after the commencement of TH, which is relatively early onset compared with previously published literature where the average age at the time of diagnosis of SCFN was 5–10 days, with some cases presenting at 30 days of age.5 7 8 At 17 days after the onset of the SCFN lesions and during a routine change of the baby’s position to supine from prone, he developed a large haematoma over his back. The persistent thrombocytopenia requiring daily platelet transfusion may have contributed to the development of the haematoma. The haematoma initially started as bleeding inside previous liquefied necrotic nodules and rapidly progressed to occupy most of his back area. This lesion required surgical draining and debridement of necrotic tissues, followed by a full-thickness skin graft.

We found three previously published case reports with similar presentations. In two of the cases, SCFN developed as a complication of TH for HIE. The first case was 1 of the 12 case series from the UK TOBY cooling register. In that case, the haematoma developed 9 days after the onset of the SCFN lesions and was treated with surgical debridement and skin graft repair.4 In the second case, the haematoma developed 16 days after the development of SCFN. It also required surgical intervention for drainage of haematoma, debridement of the necrotic tissue and skin graft.11 In the third case, the SCFN and the haematoma developed after the second week of life in a baby with sever HIE who did not receive TH.12 None of the cases suffered from thrombocytopenia before the development of the haematoma.

Hypercalcaemia is a well-known complication of SCFN occurring in about 60% of SCFN cases. Clinicians are often on the lookout for this complication. Secondary hypercalcaemia is usually asymptomatic and resolves spontaneously, but it might cause nephrocalcinosis, hypertension and seizures and requires intervention.13 Our neonate developed mild, asymptomatic hypercalcaemia on day 38 of life (maximum serum calcium level of 3.01 mmol/L), which was managed by withholding vitamin D supplementation.

This case report highlights the importance of skincare in babies undergoing TH for HIE. Infants with SCFN must be carefully screened for the presence of fluctuant swellings, discoloration and tenderness over their lesions. Additional risk factors like abnormal clotting profile or thrombocytopenia must warrant extra precautions when it comes to changing the baby’s position. It is essential to change the position of babies regularly. Special care must be taken after the development of SCFN with the utilisation of pressure-relieving mattresses and cushions when necessary.

Learning points

  • Subcutaneous fat necrosis (SCFN) is a known complication of therapeutic hypothermia in babies with hypoxic-ischaemic encephalopathy.

  • Secondary haematoma in SCFN is an infrequent complication that needs immediate attention and care.

  • Proper skin care and careful, frequent patient repositioning are crucial in babies with SCFN.

  • Early surgical involvement should be considered to minimise injury.

Footnotes

  • Twitter @haythamsanad

  • Contributors EOSE: contributed in the management of the patient, approached the parents for consent, gathered the relevant data and wrote the manuscript. PM, KY and FOGF: contributed in the management of the patient, edited and approved the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Parental/guardian consent obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer